POLETTI, BARBARA
 Distribuzione geografica
Continente #
EU - Europa 10.852
AS - Asia 8.522
NA - Nord America 7.922
SA - Sud America 891
AF - Africa 155
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 3
Totale 28.439
Nazione #
US - Stati Uniti d'America 7.570
IT - Italia 3.462
DE - Germania 2.964
CN - Cina 2.682
SG - Singapore 2.483
GB - Regno Unito 1.277
HK - Hong Kong 757
BD - Bangladesh 685
BR - Brasile 656
RU - Federazione Russa 620
VN - Vietnam 515
FR - Francia 456
IN - India 439
NL - Olanda 429
SE - Svezia 428
CA - Canada 241
KR - Corea 227
IE - Irlanda 223
FI - Finlandia 192
TR - Turchia 170
UA - Ucraina 167
ID - Indonesia 151
ES - Italia 132
JP - Giappone 103
AU - Australia 83
PL - Polonia 83
AR - Argentina 82
DK - Danimarca 76
CH - Svizzera 71
CO - Colombia 61
BE - Belgio 53
EU - Europa 51
MX - Messico 50
CI - Costa d'Avorio 46
AT - Austria 41
IQ - Iraq 39
PH - Filippine 33
IL - Israele 32
CL - Cile 26
TW - Taiwan 26
IR - Iran 25
GR - Grecia 24
ZA - Sudafrica 24
PK - Pakistan 21
SA - Arabia Saudita 21
PT - Portogallo 19
VE - Venezuela 18
HU - Ungheria 17
KE - Kenya 17
LU - Lussemburgo 17
EC - Ecuador 16
RO - Romania 16
UZ - Uzbekistan 16
CZ - Repubblica Ceca 15
EG - Egitto 14
NO - Norvegia 14
CR - Costa Rica 13
PE - Perù 13
TH - Thailandia 12
MY - Malesia 11
NZ - Nuova Zelanda 11
MA - Marocco 10
NP - Nepal 10
JO - Giordania 9
UY - Uruguay 9
JM - Giamaica 8
LT - Lituania 7
LV - Lettonia 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
DZ - Algeria 6
HN - Honduras 6
LB - Libano 6
SC - Seychelles 6
BO - Bolivia 5
CY - Cipro 5
EE - Estonia 5
LI - Liechtenstein 5
MD - Moldavia 5
NI - Nicaragua 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
DO - Repubblica Dominicana 4
GE - Georgia 4
GT - Guatemala 4
NG - Nigeria 4
SV - El Salvador 4
TN - Tunisia 4
AM - Armenia 3
BG - Bulgaria 3
ET - Etiopia 3
HR - Croazia 3
KG - Kirghizistan 3
MM - Myanmar 3
MO - Macao, regione amministrativa speciale della Cina 3
MT - Malta 3
OM - Oman 3
PR - Porto Rico 3
PS - Palestinian Territory 3
Totale 28.433
Città #
Frankfurt am Main 2.510
Singapore 1.292
Ashburn 1.018
Southend 893
Milan 716
Hong Kong 653
San Jose 591
Chandler 466
Beijing 430
Dallas 430
Hefei 399
Council Bluffs 370
Rome 242
Los Angeles 237
Seattle 215
Dublin 214
Bengaluru 210
New York 208
Fairfield 190
Princeton 176
Wilmington 166
Santa Clara 164
Ho Chi Minh City 161
Lauterbourg 159
Hanoi 142
Boardman 138
Ann Arbor 132
Jakarta 129
Jacksonville 127
Buffalo 122
Houston 117
Shanghai 109
Moscow 104
Seoul 104
Toronto 103
The Dalles 92
Woodbridge 88
Helsinki 87
Guangzhou 83
Mountain View 80
Istanbul 77
Des Moines 76
Cambridge 75
Turin 74
Munich 70
Naples 69
Nanjing 64
São Paulo 64
Redmond 60
Chicago 58
London 58
Tokyo 54
Redwood City 51
Warsaw 51
Bologna 49
Dearborn 49
Nuremberg 49
Abidjan 46
Bogotá 42
Phoenix 40
Berlin 39
Jinan 39
Cangzhou 38
Washington 38
Florence 37
Changsha 36
Lappeenranta 36
Sakarya 36
Andover 34
Brussels 34
Montreal 34
Ponte San Pietro 34
Tianjin 34
Fuzhou 32
Serra 32
Shenyang 32
Da Nang 30
San Diego 30
Bari 28
Brescia 28
Brooklyn 28
Columbus 28
Orem 28
Shenzhen 28
Atlanta 27
Genoa 27
Chennai 26
Rio de Janeiro 26
Palermo 25
Vienna 25
Wuhan 25
Padova 24
Somerville 24
Hyderabad 23
Nanchang 23
Hangzhou 22
Silver Spring 22
Amsterdam 21
Bergamo 20
Fremont 20
Totale 16.216
Nome #
Validation of a Neuro Virtual Reality-based version of the Multiple Errands Test for the assessment of Executive functions 952
Il questionario per la valutazione del significato personale (QSP) nell'approccio post-razionalista al paziente neurologico 796
The diagnosis of Amyotrophic Lateral Sclerosis 451
Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis 400
Standardization of the Italian ALS-CBS™ Caregiver Behavioral Questionnaire 394
Diagnostics and clinical usability of the Montreal Cognitive Assessment (MoCA) in amyotrophic lateral sclerosis 363
Diagnostic properties of the Italian ECAS Carer Interview (ECAS-CI) 331
Brain-Computer Interface for Clinical Purposes : Cognitive Assessment and Rehabilitation 326
Clinical usability of the Story-Based Empathy Task (SET) in non-demented ALS patients 308
The complex interplay between depression/anxiety and executive functioning : insights from the ECAS in a large ALS Population 298
The validation of the Italian Edinburgh cognitive and behavioural ALS screen (ECAS) 283
Counterfactual thinking in psychiatric and neurological diseases: A scoping review 281
The Arrows and Colors Cognitive Test (ACCT) : a new verbal-motor free cognitive measure for executive functions in ALS 276
Counterfactual thinking deficit in Huntington's disease 261
Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients 260
'Cog-markers' for the diagnosis of dementia of Alzheimer's type 256
The Frontal Assessment Battery (FAB) effectively discriminates between MCI and dementia within the clinical spectrum of neurochemically confirmed Alzheimer’s disease 254
Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis 250
Intervention for promoting breast milk use in neonatal intensive care unit : a pilot study 247
Dysgraphia in patients with primary lateral sclerosis: a speech-based rehearsal deficit? 242
Bridging the Gap of ALS Missing Heritability: Are Neurogenes Being Overlooked? 241
Association of the risk factor UNC13A with survival and upper motor neuron involvement in amyotrophic lateral sclerosis 240
Psychological Impact During the First Outbreak of COVID-19 in Italy 238
Cognitive-constructivist Approach in Medical Settings : the Use of Personal Meaning Questionnaire for Neurological Patients' Personality Investigation 235
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus 233
The impact of upper motor neuron involvement on clinical features, disease progression and prognosis in amyotrophic lateral sclerosis 232
Amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD) 231
The use of P300-based BCIs in amyotrophic lateral sclerosis : from augmentative and alternative communication to cognitive assessment 229
Cognitive-behavioral longitudinal assessment in ALS : the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS) 227
The Effects of a New Integrated and Multidisciplinary Cognitive Rehabilitation Program Based on Mindfulness and Reminiscence Therapy in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Pilot Study 225
Attachment, personality and locus of control : psychological determinants of risk perception and preventive behaviors for COVID-19 219
Long-lasting cognitive abnormalities after COVID-19 218
Diagnostic properties of the Frontal Assessment Battery (FAB) in Huntington’s disease 216
Psychometrics and diagnostics of the Italian version of the Beck Depression Inventory-II (BDI-II) in Parkinson's disease 214
An eye-tracking controlled neuropsychological battery for cognitive assessment in neurological diseases 214
A 6-month follow-up study on worry and its impact on well-being during the first wave of COVID-19 pandemic in an Italian sample 211
Verbal learning in frontal patients: area 9 is critical for employing semantic strategies 209
Bulbar involvement and cognitive features in amyotrophic lateral sclerosis: a retrospective study on 347 patients 208
Frontotemporal-spectrum disorders and functional independence in non-demented ALS patients 204
Verbal Learning Impairment in Parkinson's Disease: Role of the Frontostriatal System in Working and Strategic Memory 204
Genetics of Familial Amyotrophic Lateral Sclerosis 202
Emotional and autonomic response to visual erotic stimulation in patients with functional hypothalamic amenorrhea 201
Anodal Transcranial Direct Current Stimulation over the Cerebellum Enhances Sadness Recognition in Parkinson's Disease Patients: a Pilot Study 200
Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients 197
The Effect of Surgical Masks on the Featural and Configural Processing of Emotions 195
TMEM106B Acts as a Modifier of Cognitive and Motor Functions in Amyotrophic Lateral Sclerosis 192
Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington's disease 192
Lower semantic fluency scores and a phonemic-over-semantic advantage predict abnormal CSF P-tau181 levels in Aβ + patients within the Alzheimer's disease clinical spectrum 191
CSF Aβ40 and P-tau181 might differentiate atypical from typical AD phenotypes : preliminary evidence 190
A Novel Approach for Investigating Parkinson’s Disease Personality and Its Association With Clinical and Psychological Aspects 186
Cognitive assessment in Amyotrophic Lateral Sclerosis by means of P300-Brain Computer Interface : a preliminary study 186
Fiberoptic endoscopic evaluation of swallowing in early-to-advanced stage Huntington’s disease 184
Predictors of malnutrition risk in neurodegenerative diseases: the role of swallowing function 183
One‐Year Cognitive Follow‐Up of COVID‐19 Hospitalized Patients 182
Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis 181
Ecological Validity of the Montreal Cognitive Assessment in Non-Demented Parkinson's Disease Patients 179
A neuro VR-Based version of the multiple errands test for the assessment of executive functions; 179
Compensating for verbal-motor deficits in neuropsychological assessment in movement disorders: sensitivity and specificity of the ECAS in Parkinson’s and Huntington’s diseases 178
Relationship between Reaction Times and Post-COVID-19 Symptoms Assessed by a Web-Based Visual Detection Task 177
CSF angiogenin levels in amyotrophic lateral Sclerosis-Frontotemporal dementia spectrum 177
Telemedicine for cognitive impairment: a telephone survey of patients' experiences with neurological video consultation 176
Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson’s disease patients 175
Sexuality and intimacy in ALS: systematic literature review and future perspectives 175
Phosphorylated tau in plasma could be a biomarker of lower motor neuron impairment in amyotrophic lateral sclerosis 174
Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19 173
Modificazioni dei livelli di Brain-Derived Neurotrophic Factor (BDNF) nel siero di pazienti affetti da Malattia di Huntington 173
Role of expectations in clinical outcomes after deep brain stimulation in patients with Parkinson's disease: a systematic review 172
Frontotemporal syndromes of primary lateral sclerosis 172
Antiphospholipid syndrome and systemic lupus erythematosus patients: what's new about cognitive involvement? 171
Gaze-Contingent Eye-Tracking Training in Brain Disorders: A Systematic Review 170
Brain computer interface and eye-tracking for neuropsychological assessment of executive functions : a pilot study 169
A neuroVR based tool for cognitive assessment and rehabilitation of post-stroke patients:two case studies 167
Can total electrical energy (TEED) after subthalamic DBS alter verbal fluency in Parkinson's disease patients? A preliminary evidence 161
Cognitive effects of adaptive deep brain stimulation in Parkinson’s disease: stability without risk 161
PON1 is a disease modifier gene in amyotrophic lateral sclerosis : association of the Q192R polymorphism with bulbar onset and reduced survival 161
Emotional processing and experience in amyotrophic lateral sclerosis: A systematic and critical review 159
Aripiprazole in Huntington's disease: a first case report 158
X-linked Parkinsonism with Intellectual Disability caused by novel mutations and somatic mosaicism in RAB39B gene 158
Oropharyngeal Dysphagia Phenotypes Across Huntington’s Disease Stages: Endoscopic Findings and Tongue Pressure Analysis 157
Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis 157
Alterazione della scrittura in pazienti con Sclerosi Laterale Amiotrofica 157
Ocular Involvement Occurs Frequently at All Stages of Amyotrophic Lateral Sclerosis: Preliminary Experience in a Large Italian Cohort 157
Association of clinically evident eye movement abnormalities with motor and cognitive features in patients with motor neuron disorders 157
Low Brain-derived Neurotrophic Factor (BDNF) Levels in Serum of Huntington's Disease Patients 152
Obsessiviness as a typical personality style in PD patients. An analysis with a self rating questionnaire (QSP) 152
Influence of kidney function and CSF/serum albumin ratio on plasma Aβ42 and Aβ40 levels measured on a fully automated platform in patients with Alzheimer’s disease 151
Effectiveness of a novel cognitive rehabilitation program based on mindfulness and reminiscence in patients with Parkinson's Disease and Mild Cognitive Impairment: a pilot study 148
An exploratory study on counterfactual thinking in amyotrophic lateral sclerosis 147
An eye-tracker controlled cognitive battery : overcoming verbal-motor limitations in ALS 147
Alternate fluency in Parkinson's disease: A machine learning analysis 146
Implementation of the Multiple Errands Test in a NeuroVR-supermarket: a possible approach 146
Validating the neuro VR-based virtual version of the multiple errands test : preliminary results 145
Prevalence and determinants of language impairment in non-demented amyotrophic lateral sclerosis patients 144
Clinical usefulness of the Verbal Fluency Index (VFI) in amyotrophic lateral sclerosis 142
Feasibility and diagnostics of the Frontal Assessment Battery (FAB) in amyotrophic lateral sclerosis 142
Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis 142
Energy Delivered by Subthalamic Deep Brain Stimulation for Parkinson Disease Correlates With Depressive Personality Trait Shift 142
Telepsychotherapy: a leaflet for psychotherapists in the age of COVID-19 : a review of the evidence 141
Resilience, Psychological Well-Being and Daily Functioning Following Hospitalization for Respiratory Distress Due to SARS-CoV-2 Infection 141
Resting state functional brain networks associated with emotion processing in frontotemporal lobar degeneration 140
Totale 21.707
Categoria #
all - tutte 82.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 0 0 107
2021/20221.466 78 87 82 104 149 94 150 90 145 122 85 280
2022/20232.156 228 173 170 192 249 342 84 128 245 76 154 115
2023/20243.648 121 138 115 215 515 230 431 374 186 378 455 490
2024/20255.377 426 604 390 550 241 234 281 439 309 472 488 943
2025/202611.554 1.116 967 1.258 904 778 593 1.380 536 1.124 938 1.669 291
Totale 29.585